2-[5-(5-carbamimidoyl-1H-benzoimidazol-2-yl)-6-hydroxy-2'-methyl-biphenyl-3-yl]-succinic acid

ID: ALA204283

Chembl Id: CHEMBL204283

PubChem CID: 135532849

Max Phase: Preclinical

Molecular Formula: C25H22N4O5

Molecular Weight: 458.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccccc1-c1cc(C(CC(=O)O)C(=O)O)cc(-c2nc3cc(C(=N)N)ccc3[nH]2)c1O

Standard InChI:  InChI=1S/C25H22N4O5/c1-12-4-2-3-5-15(12)17-8-14(16(25(33)34)11-21(30)31)9-18(22(17)32)24-28-19-7-6-13(23(26)27)10-20(19)29-24/h2-10,16,32H,11H2,1H3,(H3,26,27)(H,28,29)(H,30,31)(H,33,34)

Standard InChI Key:  LLJXUBIQRITYHZ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA204283

    ---

Associated Targets(Human)

F7 Tchem Coagulation factor VII (948 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin and coagulation factor VII (175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F10 Tclin Coagulation factor VII and X (116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KLKB1 Tclin Plasma kallikrein (2047 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KLKB1 Tclin Coagulation factor X and plasma kallikrein (30 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 458.47Molecular Weight (Monoisotopic): 458.1590AlogP: 3.84#Rotatable Bonds: 7
Polar Surface Area: 173.38Molecular Species: ZWITTERIONHBA: 5HBD: 6
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.64CX Basic pKa: 10.60CX LogP: 1.51CX LogD: -0.33
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.18Np Likeness Score: -0.15

References

1. Shrader WD, Kolesnikov A, Burgess-Henry J, Rai R, Hendrix J, Hu H, Torkelson S, Ton T, Young WB, Katz BA, Yu C, Tang J, Cabuslay R, Sanford E, Janc JW, Sprengeler PA..  (2006)  Factor VIIa inhibitors: gaining selectivity within the trypsin family.,  16  (6): [PMID:16413783] [10.1016/j.bmcl.2005.12.040]
2. Young WB, Rai R, Shrader WD, Burgess-Henry J, Hu H, Elrod KC, Sprengeler PA, Katz BA, Sukbuntherng J, Mordenti J..  (2006)  Small molecule inhibitors of plasma kallikrein.,  16  (7): [PMID:16413183] [10.1016/j.bmcl.2005.12.060]

Source